Basic Information
SMOFlipid 20%
INJECTION, EMULSION
Regulatory Information
SIN13246P
April 12, 2007
General Sale List
Therapeutic
INTRAVENOUS
August 10, 2023
June 3, 2025
XB05BA02
Company Information
FRESENIUS KABI (SINGAPORE) PTE LTD
FRESENIUS KABI (SINGAPORE) PTE LTD
Active Ingredients
Strength: 60g per 1000ml
Strength: 60g per 1000ml
Strength: 30g per 1000ml
Strength: 50g per 1000ml
Detailed Information
Contraindications
**Contraindications** - Hypersensitivity to fish-, egg-, soya or peanut protein or to any of the active substances or excipients. - Severe hyperlipidemia. - Severe liver insufficiency. - Severe blood coagulation disorders. - Severe renal insufficiency without access to hemofiltration or dialysis. - Acute shock. - General contraindications to infusion therapy: acute pulmonary oedema, hyperhydration, decompensated cardiac insufficiency. - Unstable conditions (e.g. severe post-traumatic conditions, uncompensated diabetes mellitus, acute myocardial infarction, stroke, embolism, metabolic acidosis and severe sepsis and hypotonic dehydration).
Indication Information
**Indications** Supply of energy and essential fatty acids and omega-3 fatty acids to patients, as part of a parenteral nutrition regimen, when oral or enteral nutrition is impossible, insufficient or contra-indicated.